These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32973768)

  • 1. Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.
    Merlo LMF; DuHadaway JB; Montgomery JD; Peng WD; Murray PJ; Prendergast GC; Caton AJ; Muller AJ; Mandik-Nayak L
    Front Immunol; 2020; 11():1861. PubMed ID: 32973768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.
    Merlo LMF; Pigott E; DuHadaway JB; Grabler S; Metz R; Prendergast GC; Mandik-Nayak L
    J Immunol; 2014 Mar; 192(5):2082-2090. PubMed ID: 24489090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis.
    Merlo LMF; Grabler S; DuHadaway JB; Pigott E; Manley K; Prendergast GC; Laury-Kleintop LD; Mandik-Nayak L
    Clin Immunol; 2017 Jun; 179():8-16. PubMed ID: 28223071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.
    Metz R; Smith C; DuHadaway JB; Chandler P; Baban B; Merlo LM; Pigott E; Keough MP; Rust S; Mellor AL; Mandik-Nayak L; Muller AJ; Prendergast GC
    Int Immunol; 2014 Jul; 26(7):357-67. PubMed ID: 24402311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of IDO1 and IDO2 on the B Cell Immune Response.
    Merlo LMF; Peng W; Mandik-Nayak L
    Front Immunol; 2022; 13():886225. PubMed ID: 35493480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism.
    Merlo LM; DuHadaway JB; Grabler S; Prendergast GC; Muller AJ; Mandik-Nayak L
    J Immunol; 2016 Jun; 196(11):4487-97. PubMed ID: 27183624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunomodulatory Enzyme IDO2 Mediates Autoimmune Arthritis through a Nonenzymatic Mechanism.
    Merlo LMF; Peng W; DuHadaway JB; Montgomery JD; Prendergast GC; Muller AJ; Mandik-Nayak L
    J Immunol; 2022 Feb; 208(3):571-581. PubMed ID: 34965962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive.
    Godin-Ethier J; Hanafi LA; Duvignaud JB; Leclerc D; Lapointe R
    Mol Immunol; 2011 Oct; 49(1-2):253-9. PubMed ID: 21937116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation.
    Qian F; Liao J; Villella J; Edwards R; Kalinski P; Lele S; Shrikant P; Odunsi K
    Cancer Immunol Immunother; 2012 Nov; 61(11):2013-20. PubMed ID: 22527253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection.
    Huang L; Li L; Klonowski KD; Tompkins SM; Tripp RA; Mellor AL
    PLoS One; 2013; 8(6):e66546. PubMed ID: 23785507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.
    Liu X; Shin N; Koblish HK; Yang G; Wang Q; Wang K; Leffet L; Hansbury MJ; Thomas B; Rupar M; Waeltz P; Bowman KJ; Polam P; Sparks RB; Yue EW; Li Y; Wynn R; Fridman JS; Burn TC; Combs AP; Newton RC; Scherle PA
    Blood; 2010 Apr; 115(17):3520-30. PubMed ID: 20197554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity.
    Merlo LM; Mandik-Nayak L
    Clin Med Insights Pathol; 2016; 9(Suppl 1):21-28. PubMed ID: 27891058
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Fujii K; Yamamoto Y; Mizutani Y; Saito K; Seishima M
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752186
    [No Abstract]   [Full Text] [Related]  

  • 15. Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice.
    Pigott E; Mandik-Nayak L
    Arthritis Rheum; 2012 Jul; 64(7):2169-78. PubMed ID: 22294267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.
    Trabanelli S; Očadlíková D; Ciciarello M; Salvestrini V; Lecciso M; Jandus C; Metz R; Evangelisti C; Laury-Kleintop L; Romero P; Prendergast GC; Curti A; Lemoli RM
    J Immunol; 2014 Feb; 192(3):1231-40. PubMed ID: 24391212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG
    Wetzel LA; Hurtado M; MacDowell Kaswan ZA; McCusker RH; Steelman AJ
    Brain Behav Immun Health; 2020 Aug; 7():100116. PubMed ID: 34589873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.
    He G; Wan S; Wu Y; Chu Z; Shen H; Zhang S; Chen L; Bao Z; Gu S; Huang J; Huang L; Gong G; Zou Y; Zhu Q; Xu Y
    J Med Chem; 2022 Nov; 65(21):14348-14365. PubMed ID: 35952367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDO1 and IDO2 gene expression analysis by quantitative polymerase chain reaction.
    Maiwald S; Wehner R; Schmitz M; Bornhäuser M; Loeb S; Wassmuth R
    Tissue Antigens; 2011 Feb; 77(2):136-42. PubMed ID: 21092022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.